DIRAS1 and metastatic malignant neoplasm in the lymph nodes: A study indicates that low level of DIRAS1 is significantly associated with advanced clinical stage and lymph node metastasis in patients with esophageal squamous cell carcinoma.10 Unfortunately, this study failed to better complete patient follow-up and tracking to analyze the correlation between DIRAS1 expression and patient prognosis.